Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Meltzer

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Parallel synthesis of a series of subtype-selective NMDA receptor antagonistsT F Gregory, J L Wright, L D Wise, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonistT A Pugsley, C L Christofferson, A Corbin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomersL T Meltzer, B W Caprathe, C L Christoffersen, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Parallel synthesis of a series of subtype-selective NMDA receptor antagonistsT F Gregory, J L Wright, L D Wise, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effectsL T Meltzer, C L Christoffersen, A E Corbin, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonistT A Pugsley, C L Christofferson, A Corbin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomersL T Meltzer, B W Caprathe, C L Christoffersen, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pageof 5